Home Nightstar Therapeutics

Nightstar Therapeutics

acquired
IPO
Biopharmaceutical Manufacturer
Basic
Enterprise Profile

Basic Information

Nightstar is a biopharmaceutical company focused on developing gene therapies for retinal dystrophies.
NightstaRx Limited
London,England,United Kingdom
15~50 people
January 01, 2013
enquiries@nightstartx.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Gene Therapy
Technology
Gene Technology Biotechnology
Concept
Ophthalmology
Application Scenarios
Medical Devices